Document is current
Any future updates will be listed below
-
Authors
Jakobsen Falk, Ingrid https://orcid.org/0000-0003-4450-0333
Lund, Johan
Gréen, Henrik
Gruber, Astrid
Alici, Evren
Lauri, Birgitta
Blimark, Cecilie
Mellqvist, Ulf-Henrik
Swedin, Agneta
Forsberg, Karin
Carlsson, Conny
Hardling, Mats
Ahlberg, Lucia
Lotfi, Kourosh
Nahi, Hareth
-
Funding
Funding for this research was provided by:
Cancerfonden (2016/602, 2013/487)
Vetenskapsrådet (C0592901)
AFA Försäkring (100158)
Celgene
Region Östergötland (LIO-608001 and LIO-535801)
Linköpings Universitet
- License Information
-
More Information
Article History
Received: 29 May 2017
Accepted: 12 November 2017
First Online: 25 November 2017
Change Date: 12 April 2025
Change Type: Update
Change Details: The Supplementary material has been included.
Compliance with ethical standards
:
: MH has received personal fees from Celgene, Janssen, Amgen, and Takeda. U-HM has received honoraria from Amgen, Novartis, Celgene, and Mundipharma, and has served on advisory boards for Amgen and Takeda. The remaining authors declare no competing financial interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
